Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Challenges and opportunities in productivity and sustainability of rice cultivation system: a critical review in Indian perspective.
Kumar N, Chhokar RS, Meena RP, Kharub AS, Gill SC, Tripathi SC, Gupta OP, Mangrauthia SK, Sundaram RM, Sawant CP, Gupta A, Naorem A, Kumar M, Singh GP. Kumar N, et al. Among authors: gill sc. Cereal Res Commun. 2022;50(4):573-601. doi: 10.1007/s42976-021-00214-5. Epub 2021 Oct 8. Cereal Res Commun. 2022. PMID: 34642509 Free PMC article. Review.
Gilteritinib as Post-Transplant Maintenance for Acute Myeloid Leukemia With Internal Tandem Duplication Mutation of FLT3.
Levis MJ, Hamadani M, Logan B, Jones RJ, Singh AK, Litzow M, Wingard JR, Papadopoulos EB, Perl AE, Soiffer RJ, Ustun C, Ueda Oshima M, Uy GL, Waller EK, Vasu S, Solh M, Mishra A, Muffly L, Kim HJ, Mikesch JH, Najima Y, Onozawa M, Thomson K, Nagler A, Wei AH, Marcucci G, Geller NL, Hasabou N, Delgado D, Rosales M, Hill J, Gill SC, Nuthethi R, King D, Wittsack H, Mendizabal A, Devine SM, Horowitz MM, Chen YB; BMT-CTN 1506/MORPHO Study Investigators. Levis MJ, et al. Among authors: gill sc. J Clin Oncol. 2024 Mar 12:JCO2302474. doi: 10.1200/JCO.23.02474. Online ahead of print. J Clin Oncol. 2024. PMID: 38471061
Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML.
Pratz KW, Cherry M, Altman JK, Cooper BW, Podoltsev NA, Cruz JC, Lin TL, Schiller GJ, Jurcic JG, Asch A, Wu R, Hill JE, Gill SC, James AJ, Rich ES, Hasabou N, Perl AE, Levis MJ. Pratz KW, et al. Among authors: gill sc. J Clin Oncol. 2023 Sep 10;41(26):4236-4246. doi: 10.1200/JCO.22.02721. Epub 2023 Jun 28. J Clin Oncol. 2023. PMID: 37379495 Clinical Trial.
Unveiling the Wheat Microbiome under Varied Agricultural Field Conditions.
Jaiswal S, Aneja B, Jagannadham J, Pandey B, Chhokar RS, Gill SC, Ahlawat OP, Kumar A, Angadi UB, Rai A, Tiwari R, Iquebal MA, Kumar D. Jaiswal S, et al. Among authors: gill sc. Microbiol Spectr. 2022 Dec 21;10(6):e0263322. doi: 10.1128/spectrum.02633-22. Epub 2022 Nov 29. Microbiol Spectr. 2022. PMID: 36445165 Free PMC article.
Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3mut+ AML ineligible for intensive chemotherapy.
Wang ES, Montesinos P, Minden MD, Lee JH, Heuser M, Naoe T, Chou WC, Laribi K, Esteve J, Altman JK, Havelange V, Watson AM, Gambacorti-Passerini C, Patkowska E, Liu S, Wu R, Philipose N, Hill JE, Gill SC, Rich ES, Tiu RV. Wang ES, et al. Among authors: gill sc. Blood. 2022 Oct 27;140(17):1845-1857. doi: 10.1182/blood.2021014586. Blood. 2022. PMID: 35917453 Free PMC article. Clinical Trial.
Binding Modes and Metabolism of Caffeine.
Jandova Z, Gill SC, Lim NM, Mobley DL, Oostenbrink C. Jandova Z, et al. Among authors: gill sc. Chem Res Toxicol. 2019 Jul 15;32(7):1374-1383. doi: 10.1021/acs.chemrestox.9b00030. Epub 2019 Jun 11. Chem Res Toxicol. 2019. PMID: 31132250 Free PMC article.
36 results